are hims glp 1 safe offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly Hims expansion may not come

Shares of Novo Nordisk, the dominant player in the weight-loss drug market, have surged 447% over the past five years as it rolled out some of the first GLP-1 medication brands, but the company has also faced supply constraints due to growing demand

The reason for this wait, also called a deferral period, is because CSL is mandated to comply with various global regulatory requirements

And I cannot overstate the slippery slope GLP-1s create for those with a history of disordered eating or body image struggles (and lets be honest thats a lot of the people who feel drawn to these medications)

Grocery spend by households that include a weight loss jab user has declined by 780m, with 299m fewer items bought during February, when the analysis took place

Both medications show similar lean mass preservation ratios, but Retatrutide achieves greater total fat loss